Clinical and anatomic pathology laboratories that pay referral sources for processing and handling (P&H) of specimens are reassessing their business models in light of a recent special fraud alert issued by the Health and Human Services Office of Inspector General (OIG). For example, Richmond, Va.-based Health Diagnostic Laboratory Inc. (HDL) has stopped offering reimbursements to…

This content is for Paid Members only.
Login Register